MAPT and supranuclear palsy, progressive, 1: In order to selectively biotinylate proteins in a small radius to phosphorylated Tau in PSP patient post‐mortem tissue, we first targeted phosphorylated forms of Tau using a primary mouse antibody that recognizes p‐Tau at serine 202 (S202) and threonine 205 (T205).